#Isomorphic Labs
Articles
Market
Isomorphic Labs raises $5 billion Series C co-led by Greenoaks and Sequoia with a16z joining, while its first AI-designed drugs remain preclinical and no valuation is disclosed
Isomorphic Labs raised $5B in a Series C co-led by Greenoaks and Sequoia. Its drugs are still preclinical and no valuation was disclosed.